Literature DB >> 29155998

Limited Impact of Adolescent Meningococcal ACWY Vaccination on Neisseria meningitidis Serogroup W Carriage in University Students.

Neil J Oldfield1, Luke R Green2, Julian Parkhill3, Christopher D Bayliss2, David P J Turner1.   

Abstract

Background: In the United Kingdom, rising levels of disease due to Neisseria meningitidis serogroup W clonal complex (cc) sequence type (ST) 11 (MenW:cc11) strains led to introduction of meningococcal conjugate vaccine (MenACWY) for teenagers. We investigated the impact of immunization on carriage of meningococci targeted by the vaccine, using whole-genome sequencing of isolates recovered from a cohort of vaccinated university students.
Methods: Strain designation data were extracted from whole-genome sequencing data. Genomes from carried and invasive MenW:cc11 strains were compared using a gene-by-gene approach. Serogrouping identified isolates expressing capsule antigens targeted by the vaccine.
Results: Isolates with a W: P1.5,2: F1-1: ST-11 (cc11) designation and belonging to the emerging 2013-strain of the South American-United Kingdom MenW:cc11 sublineage were responsible for an increase in carried group W strains. A multifocal expansion was evident, with close transmission networks extending beyond individual dormitories. Carried group Y isolates were predominantly from cc23 but showed significant heterogeneity, and individual strain designations were only sporadically recovered. No shifts toward acapsulate phenotypes were detected in targeted meningococcal populations. Conclusions: In a setting with high levels of MenACWY use, expansion of capsule-expressing isolates from the 2013-strain of MenW:cc11 but not MenY:cc23 isolates is indicative of differential susceptibilities to vaccine-induced immunity.
© The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Neisseria; carriage; epidemiology; genome sequencing; meningitidis; serogroup W; serogroup Y; vaccine; whole

Mesh:

Substances:

Year:  2018        PMID: 29155998      PMCID: PMC5853931          DOI: 10.1093/infdis/jix596

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  38 in total

1.  Targeted vaccination of teenagers following continued rapid endemic expansion of a single meningococcal group W clone (sequence type 11 clonal complex), United Kingdom 2015.

Authors:  H Campbell; V Saliba; R Borrow; M Ramsay; S N Ladhani
Journal:  Euro Surveill       Date:  2015-07-16

2.  Genetic mechanisms for loss of encapsulation in polysialyltransferase-gene-positive meningococci isolated from healthy carriers.

Authors:  Martin V R Weber; Heike Claus; Martin C J Maiden; Matthias Frosch; Ulrich Vogel
Journal:  Int J Med Microbiol       Date:  2006-07-28       Impact factor: 3.473

Review 3.  Biology and pathogenesis of the evolutionarily successful, obligate human bacterium Neisseria meningitidis.

Authors:  David S Stephens
Journal:  Vaccine       Date:  2009-05-23       Impact factor: 3.641

4.  University vaccine campaign increases meningococcal ACWY vaccine coverage.

Authors:  D P J Turner; N J Oldfield; C D Bayliss
Journal:  Public Health       Date:  2017-01-12       Impact factor: 2.427

5.  Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity.

Authors:  Paul A Kristiansen; Fabien Diomandé; Absatou Ky Ba; Idrissa Sanou; Abdoul-Salam Ouédraogo; Rasmata Ouédraogo; Lassana Sangaré; Denis Kandolo; Flavien Aké; Inger Marie Saga; Thomas A Clark; Lara Misegades; Stacey W Martin; Jennifer Dolan Thomas; Sylvestre R Tiendrebeogo; Musa Hassan-King; Mamoudou H Djingarey; Nancy E Messonnier; Marie-Pierre Préziosi; F Marc Laforce; Dominique A Caugant
Journal:  Clin Infect Dis       Date:  2012-10-19       Impact factor: 9.079

6.  Increase in endemic Neisseria meningitidis capsular group W sequence type 11 complex associated with severe invasive disease in England and Wales.

Authors:  Shamez N Ladhani; Kazim Beebeejaun; Jay Lucidarme; Helen Campbell; Steve Gray; Ed Kaczmarski; Mary E Ramsay; Ray Borrow
Journal:  Clin Infect Dis       Date:  2014-11-10       Impact factor: 9.079

7.  Notes from the Field: Outbreak of Serogroup B Meningococcal Disease at a University - California, 2016.

Authors:  Hope H Biswas; George S Han; Kristen Wendorf; Kathleen Winter; Jennifer Zipprich; Tara Perti; Linda Martinez; Aileen Arellano; Jennifer L Kyle; Peng Zhang; Kathleen Harriman
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-05-27       Impact factor: 17.586

8.  Serogroup B Meningococcal Disease Outbreak and Carriage Evaluation at a College - Rhode Island, 2015.

Authors:  Heidi M Soeters; Lucy A McNamara; Melissa Whaley; Xin Wang; Nicole Alexander-Scott; Koren V Kanadanian; Catherine M Kelleher; Jessica MacNeil; Stacey W Martin; Nathan Raines; Steven Sears; Cynthia Vanner; Jeni Vuong; Utpala Bandy; Kenneth Sicard; Manisha Patel
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-06-12       Impact factor: 17.586

9.  An international invasive meningococcal disease outbreak due to a novel and rapidly expanding serogroup W strain, Scotland and Sweden, July to August 2015.

Authors:  Jay Lucidarme; Kevin J Scott; Roisin Ure; Andrew Smith; Diane Lindsay; Bianca Stenmark; Susanne Jacobsson; Hans Fredlund; J Claire Cameron; Alison Smith-Palmer; Jim McMenamin; Steve J Gray; Helen Campbell; Shamez Ladhani; Jamie Findlow; Paula Mölling; Ray Borrow
Journal:  Euro Surveill       Date:  2016-11-10

Review 10.  Meningococcal carriage and disease--population biology and evolution.

Authors:  Dominique A Caugant; Martin C J Maiden
Journal:  Vaccine       Date:  2009-05-21       Impact factor: 3.641

View more
  9 in total

1.  Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020.

Authors:  Sarah A Mbaeyi; Catherine H Bozio; Jonathan Duffy; Lorry G Rubin; Susan Hariri; David S Stephens; Jessica R MacNeil
Journal:  MMWR Recomm Rep       Date:  2020-09-25

2.  Incidence of Meningococcal Disease Before and After Implementation of Quadrivalent Meningococcal Conjugate Vaccine in the United States.

Authors:  Sarah Mbaeyi; Tracy Pondo; Amy Blain; David Yankey; Caelin Potts; Amanda Cohn; Susan Hariri; Nong Shang; Jessica R MacNeil
Journal:  JAMA Pediatr       Date:  2020-09-01       Impact factor: 16.193

Review 3.  Impact of meningococcal vaccination on carriage and disease transmission: A review of the literature.

Authors:  Paul Balmer; Cynthia Burman; Lidia Serra; Laura J York
Journal:  Hum Vaccin Immunother       Date:  2018-05-09       Impact factor: 3.452

4.  B Part of It School Leaver protocol: an observational repeat cross-sectional study to assess the impact of a meningococcal serogroup B (4CMenB) vaccine programme on carriage of Neisseria meningitidis.

Authors:  Helen S Marshall; Mark McMillan; Ann Koehler; Andrew Lawrence; Jenny MacLennan; Martin Maiden; Mary Ramsay; Shamez N Ladhani; Caroline Trotter; Ray Borrow; Adam Finn; Thomas Sullivan; Peter Richmond; Charlene Kahler; Jane Whelan; Kumaran Vadivelu
Journal:  BMJ Open       Date:  2019-05-06       Impact factor: 2.692

5.  Potentiation of Phase Variation in Multiple Outer-Membrane Proteins During Spread of the Hyperinvasive Neisseria meningitidis Serogroup W ST-11 Lineage.

Authors:  Luke R Green; Neelam Dave; Adeolu B Adewoye; Jay Lucidarme; Stephen A Clark; Neil J Oldfield; David P J Turner; Ray Borrow; Christopher D Bayliss
Journal:  J Infect Dis       Date:  2019-08-30       Impact factor: 5.226

6.  Rapid Transmission of a Hyper-Virulent Meningococcal Clone Due to High Effective Contact Numbers and Super Spreaders.

Authors:  Jonathan C Holmes; Luke R Green; Neil J Oldfield; David P J Turner; Christopher D Bayliss
Journal:  Front Genet       Date:  2020-12-07       Impact factor: 4.599

7.  Genomic Insights on Variation Underlying Capsule Expression in Meningococcal Carriage Isolates From University Students, United States, 2015-2016.

Authors:  Melissa J Whaley; Jeni T Vuong; Nadav Topaz; How-Yi Chang; Jennifer Dolan Thomas; Laurel T Jenkins; Fang Hu; Susanna Schmink; Evelene Steward-Clark; Marsenia Mathis; Lorraine D Rodriguez-Rivera; Adam C Retchless; Sandeep J Joseph; Alexander Chen; Anna M Acosta; Lucy McNamara; Heidi M Soeters; Sarah Mbaeyi; Henju Marjuki; Xin Wang
Journal:  Front Microbiol       Date:  2022-02-17       Impact factor: 5.640

8.  Recent changes of invasive meningococcal disease in France: arguments to revise the vaccination strategy in view of those of other countries.

Authors:  Muhamed-Kheir Taha; Joël Gaudelus; Ala-Eddine Deghmane; François Caron
Journal:  Hum Vaccin Immunother       Date:  2020-03-25       Impact factor: 3.452

9.  'Be on the TEAM' Study (Teenagers Against Meningitis): protocol for a controlled clinical trial evaluating the impact of 4CMenB or MenB-fHbp vaccination on the pharyngeal carriage of meningococci in adolescents.

Authors:  Jeremy Carr; Emma Plested; Parvinder Aley; Susana Camara; Kimberly Davis; Jenny M MacLennan; Steve Gray; Saul N Faust; Ray Borrow; Hannah Christensen; Caroline Trotter; Martin C J Maiden; Adam Finn; Matthew D Snape
Journal:  BMJ Open       Date:  2020-10-22       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.